Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Bad
|
|
New words:
Agreementto, Asia, ASU, ASX, Australia, Becausethere, classification, Concentration, departure, discount, Distinguishing, draft, face, FASB, feature, grantee, grantor, guarantee, Healthcare, Hedging, Impression, inception, joint, key, lender, memorandum, modified, MOU, nonemployee, Payableto, prepay, publicly, purported, remit, Riskto, round, scope, Southeast, speak, tentatively, travel, unreimbursed, venture, Zealand
Removed:
abandoned, abandonment, absence, abuse, accruing, acted, addiction, addressed, advanced, agent, analytical, announced, announcement, ASC, began, begun, bifurcation, Biovail, blocker, bring, California, Capitalized, cell, closed, Codification, combined, commenced, commitment, commonly, concurrently, conditioned, confirm, consecutive, Covance, criteria, deduction, delinquent, detail, diligently, director, disagreement, earned, excluding, exit, experienced, expiring, extinguished, federally, field, footnote, forgave, forgive, forgiven, germane, hiring, host, injectable, install, instituted, instrument, insured, intent, International, invested, irrevocable, Irvine, joined, Kathryn, labeling, MacFarlane, mandatorily, methamphetamine, NIDA, November, occurrence, originally, OTC, owe, owing, parent, partial, periodic, permanent, project, promptly, ratio, reacquire, redeemable, redemption, reestablish, renamed, resulted, revalued, review, revise, revised, Robert, Sapirstein, sedative, served, Sharp, sickle, sponsored, SRL, storage, superseded, trained, UCI, unit, unlimited, Valeant, vested, volume, Weingarten, whichever
Filing tables
Filing exhibits
RSPI similar filings
Filing view
External links
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
UNDER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, James S. Manuso, the Chief Executive Officer of RespireRx Pharmaceuticals Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:
| (i) | The Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and | |
| (ii) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
| Date: May 20, 2019 | By: | /s/ ARNOLD S. LIPPA |
| Arnold S. Lippa | ||
| Interim Chief Executive Officer |